This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Randolph, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Randolph, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 114 No. 2 August 2004, pp. 525

SUPPLEMENT ARTICLE

LACK OF EFFECT OF FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY ON THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN 2- AND 3-YEAR-OLD PATIENTS

Christopher Randolph, MD

Waterbury, CT

The first 20% of the full text of this article appears below.

Galant SP, Melamed IR, Nayak AS, et al. Pediatrics. 2003;112:96–100


   Purpose of the Study.
 
To determine the effects of fluticasone propionate (FP) (200 µg daily) on the hypothalamic-pituitary-adrenal (HPA) axis among patients 2 to 3 years of age.


   Study Population.
 
Children 2 to 3 years of age who demonstrated positive skin test responses to ≥1 seasonal allergen and the presence of nasal symptoms . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?